Yi-jun J. Hua
651 Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma.
Journal: JAMA oncology
Published: March 19, 2026
Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: February 10, 2026
Induction versus Concurrent Chemotherapy for Advanced Nasopharyngeal Carcinoma.
Journal: NEJM evidence
Published: April 22, 2025
TQB2450 plus intensity-modulated radiotherapy in recurrent nasopharyngeal carcinoma: An open-label, single-arm, phase II trial.
Journal: Med (New York, N.Y.)
Published: April 17, 2025
Nasopharyngeal carcinoma detected noninvasively in the real world using three gene methylation analyses from automatically processed bilateral nasal swab samples.
Journal: BMC cancer
Published: December 13, 2024
Radiation-induced rhinosinusitis in patients with nasopharyngeal carcinoma.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 23, 2024
Prevalence of mental disorders and their associations with age at diagnosis and time since diagnosis of nasopharyngeal cancer.
Journal: Frontiers in public health
Published: July 23, 2024
Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy-Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial.
Journal: JAMA network open
Published: July 27, 2023
A phase 2 trial of gemcitabine plus toripalimab for cisplatin-ineligible patients with recurrent or metastatic nasopharyngeal carcinoma.
Journal: Cell reports. Medicine
Published: July 23, 2023
A novel endoscopic nasopharyngectomy by low-temperature plasma radiofrequency ablation in localized recurrent nasopharyngeal carcinoma.
Journal: Head & neck
Published: May 11, 2023
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial.
Journal: Cell reports. Medicine
Published: March 17, 2023
Last Updated: 09/26/2026